Cargando…
Heterogeneous expression of ACE2 and TMPRRS2 in mesenchymal stromal cells
The outbreak of COVID‐19 has become a serious public health emergency. The virus targets cells by binding the ACE2 receptor. After infection, the virus triggers in some humans an immune storm containing the release of proinflammatory cytokines and chemokines followed by multiple organ failure. Sever...
Autores principales: | Generali, Melanie, Kehl, Debora, Wanner, Debora, Okoniewski, Michal J., Hoerstrup, Simon P., Cinelli, Paolo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8742235/ https://www.ncbi.nlm.nih.gov/pubmed/34821008 http://dx.doi.org/10.1111/jcmm.17048 |
Ejemplares similares
-
Proteomic analysis of human mesenchymal stromal cell secretomes: a systematic comparison of the angiogenic potential
por: Kehl, Debora, et al.
Publicado: (2019) -
Xeno-free induced pluripotent stem cell-derived neural progenitor cells for in vivo applications
por: Rust, Ruslan, et al.
Publicado: (2022) -
Angiotensin-converting enzymes (ACE, ACE2) gene variants and COVID-19 outcome
por: Gómez, Juan, et al.
Publicado: (2020) -
Molecular simulation of SARS-CoV-2 spike protein binding to pangolin ACE2 or human ACE2 natural variants reveals altered susceptibility to infection
por: Wang, Jingfang, et al.
Publicado: (2020) -
Serum levels of ACE2 are higher in patients with obesity and diabetes
por: Emilsson, Valur, et al.
Publicado: (2020)